Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
74.34
-3.86 (-4.94%)
At close: Jul 31, 2026, 4:00 PM EDT
74.75
+0.41 (0.55%)
After-hours: Jul 31, 2026, 7:34 PM EDT

KNSA Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
243.6214.27202.13180.86156.8137.79122.54112.21108.6379.8683.467.0571.4748.3561.8899.1426.9732.1918.7512.1
Revenue Growth
55.36%55.51%64.95%61.17%44.34%72.54%46.93%67.37%51.99%65.18%34.76%-32.37%164.99%50.19%230.14%719.64%250.10%---
Gross Profit
220.03193.47181.18160.6138.19119.92104.6492.1196.3169.2873.8157.9663.7741.3155.1792.221.9427.9714.889.33
Operating Income
27.1929.2719.7724.0220.1613.27-19.3-9.66-0.12-16.540.08-10.93-3.15-11.26.0546.41-19.37-23.32-36.13-30.67
Net Income
25.4322.5914.218.4417.838.54-8.89-12.69-3.91-17.725.24-13.8614.97-12.274.46224.09-19.98-25.21-36.33-30.54
Earnings Per Share
0.300.27-0.190.230.230.11-0.12-0.18-0.06-0.250.35-0.200.21-0.180.063.18-0.29-0.36-0.53-0.44
EPS Growth
30.44%145.46%--------483.33%---------

Revenue by Geography

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24
United States
243.12214.07201.94180.71156.51137.6122.18111.94108.578.82
United Kingdom
0.480.20.190.150.290.190.360.280.060.24
Revenue (Total)
243.6214.27202.13180.86156.8137.79122.54112.21108.6379.86

Cash & Debt

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
525.93468.09414.07352.1307.78268.34243.63223.78218.76213.55206.37201.08184.99187.49190.61200.72138.21145.58182.2200.18
Total Debt
8.99.039.59.729.779.929.8610.611.412.1412.2612.9613.525.625.926.714.615.416.056.75
Net Cash (Debt)
517.03459.07404.58342.38298.02258.43233.77213.19207.36201.41194.11188.12171.47181.88184.69194.02133.59140.17176.15193.44
Net Cash Growth
73.49%77.64%73.06%60.60%43.72%28.31%20.43%13.32%20.93%10.74%5.10%-3.04%28.35%29.76%4.85%0.30%-39.20%-45.55%-44.34%-46.69%
Net Cash Per Share
6.205.574.964.283.823.393.232.972.922.852.672.682.392.612.592.751.932.032.552.82

Cash Flow & CapEx

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
47.250.253.8933.6828.0922.3218.77-2.245.173.994.3316.99-3.74-4.27-11.5862.05-7.82-36.85-18.88-28.51
Capital Expenditures
-0.66-0.16-0.63-0.67-0.17-0.1-0.1900-0.08-0.06-0.02-0.03-0.020.03-0.02-0.12--0.25-0.05
Free Cash Flow
46.5350.0453.2633.0127.9322.2318.58-2.245.173.94.2716.97-3.78-4.29-11.5462.03-7.94-36.85-19.14-28.56
Free Cash Flow Growth
66.63%125.14%186.70%-440.34%469.43%335.16%-----72.64%--------

Margins

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
90.32%90.29%89.64%88.80%88.14%87.03%85.40%82.08%88.66%86.75%88.51%86.45%89.23%85.45%89.16%93.00%81.35%86.89%79.37%77.12%
Operating Margin
11.16%13.66%9.78%13.28%12.86%9.63%-15.75%-8.61%-0.11%-20.71%0.10%-16.30%-4.41%-23.16%9.77%46.82%-71.81%-72.44%-192.75%-253.55%
Pretax Margin
12.79%15.25%11.51%15.02%14.59%11.30%-13.86%-6.42%2.12%-17.88%2.94%-12.68%-1.73%-19.37%11.05%47.14%-71.43%-72.34%-192.34%-253.51%
Profit Margin
10.44%10.54%7.02%10.19%11.37%6.20%-7.25%-11.31%-3.60%-22.17%30.26%-20.66%20.95%-25.38%7.21%226.05%-74.08%-78.32%-193.83%-252.53%
FCF Margin
19.10%23.35%26.35%18.25%17.81%16.13%15.16%-1.99%4.76%4.89%5.12%25.31%-5.28%-8.88%-18.65%62.57%-29.43%-114.47%-102.08%-236.13%

Valuation

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
101.5185.9855.0086.29691.75----179.3687.70-4.313.885.766.42----
Forward PE
50.4540.1327.3224.8529.2021.6042.93107.1282.50179.36170.84170.84170.84170.84170.84-----
P/FCF Ratio
27.2722.4823.0728.7930.8136.9756.44162.4043.7865.4093.83-23.2419.64183.11-----
PS Ratio
5.934.904.644.903.873.363.394.693.924.634.574.913.513.184.745.047.479.7321.09-